• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性和非酒精性脂肪性肝病自然史的比较。

Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.

作者信息

Mills Shane J, Harrison Stephen A

机构信息

Department of Medicine, Gastroenterology and Hepatology Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234-6200, USA.

出版信息

Curr Gastroenterol Rep. 2005 Feb;7(1):32-6. doi: 10.1007/s11894-005-0063-4.

DOI:10.1007/s11894-005-0063-4
PMID:15701296
Abstract

Fatty liver disease represents a common clinical entity. It is classically divided into alcoholic fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). Whereas AFLD occurs in as many as 10 million Americans, NAFLD represents the most common chronic liver disease and is the most common cause of liver enzyme abnormalities in the United States. Both diseases encompass the clinical spectrum of steatosis, steatohepatitis, and cirrhosis. Although they are histologically indistinct, AFLD and NAFLD follow different clinical courses. This article compares the natural history of these diseases.

摘要

脂肪性肝病是一种常见的临床病症。传统上它分为酒精性脂肪性肝病(AFLD)和非酒精性脂肪性肝病(NAFLD)。多达1000万美国人患有AFLD,而NAFLD是美国最常见的慢性肝病,也是肝酶异常最常见的原因。这两种疾病都涵盖了脂肪变性、脂肪性肝炎和肝硬化的临床谱。尽管它们在组织学上难以区分,但AFLD和NAFLD的临床病程不同。本文比较了这些疾病的自然史。

相似文献

1
Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.酒精性和非酒精性脂肪性肝病自然史的比较。
Curr Gastroenterol Rep. 2005 Feb;7(1):32-6. doi: 10.1007/s11894-005-0063-4.
2
[Non-alcoholic steatohepatitis - from NAFLD to MAFLD].[非酒精性脂肪性肝炎——从非酒精性脂肪性肝病到代谢相关脂肪性肝病]
Ther Umsch. 2011 Apr;68(4):183-8. doi: 10.1024/0040-5930/a000148.
3
Nonalcoholic steatohepatitis.非酒精性脂肪性肝炎
Semin Liver Dis. 2004 Feb;24(1):3-20. doi: 10.1055/s-2004-823098.
4
Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study.脂肪肝住院患者的癌症风险:一项丹麦队列研究。
J Clin Gastroenterol. 2003 Apr;36(4):356-9. doi: 10.1097/00004836-200304000-00015.
5
The Effects of Hepatic Steatosis on the Natural History of HBV Infection.肝脂肪变对乙型肝炎病毒感染自然史的影响。
Clin Liver Dis. 2019 Aug;23(3):433-450. doi: 10.1016/j.cld.2019.05.001.
6
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.伴有非酒精性脂肪性肝病/非酒精性脂肪性肝炎的丙型肝炎病毒相关肝硬化中的肝细胞癌的特殊组织学变异型:脂肪性肝炎相关肝细胞癌。
Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.
7
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.代谢性脂肪变性的定义与自然史:非酒精性脂肪性肝病、非酒精性脂肪性肝炎及肝硬化的临床特征
Diabetes Metab. 2008 Dec;34(6 Pt 2):634-7. doi: 10.1016/S1262-3636(08)74597-X.
8
Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.非酒精性脂肪性肝病组织学亚表型的肝脏、心血管和内分泌结局
Semin Liver Dis. 2008 Nov;28(4):380-5. doi: 10.1055/s-0028-1091982. Epub 2008 Oct 27.
9
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
10
Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile.巴西的非酒精性脂肪性肝病。临床和组织学特征。
Ann Hepatol. 2011 Jan-Mar;10(1):33-7.

引用本文的文献

1
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?酒精性和非酒精性脂肪肝的下游常见分子事件有哪些?
Lipids Health Dis. 2024 Feb 8;23(1):41. doi: 10.1186/s12944-024-02031-1.
2
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.酒精性肝病中调节肠道微生物群的药物:宿主代谢与肠道微生物群之间的联系
Front Med (Lausanne). 2022 Jul 22;9:913842. doi: 10.3389/fmed.2022.913842. eCollection 2022.
3
Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet Hamsters.

本文引用的文献

1
Epidemiology of alcoholic liver disease.酒精性肝病的流行病学
Semin Liver Dis. 2004 Aug;24(3):217-32. doi: 10.1055/s-2004-832936.
2
Nonalcoholic fatty liver disease in the pediatric population.儿科人群中的非酒精性脂肪性肝病
Clin Liver Dis. 2004 Aug;8(3):549-58, viii-ix. doi: 10.1016/j.cld.2004.04.010.
3
Nonalcoholic fatty liver disease in individuals with severe obesity.严重肥胖个体中的非酒精性脂肪性肝病
摄入深海水中溶解的有机物可改善高脂饮食仓鼠的高脂血症,抑制血栓形成和血管炎症。
Life (Basel). 2022 Jan 7;12(1):82. doi: 10.3390/life12010082.
4
Epidemiology of Alcohol-Associated Liver Disease.酒精相关性肝病的流行病学。
Clin Liver Dis. 2021 Aug;25(3):483-492. doi: 10.1016/j.cld.2021.03.009. Epub 2021 May 26.
5
Alcohol-Associated Liver Disease: East Versus West.酒精性肝病:东方与西方
Clin Liver Dis (Hoboken). 2021 Jan 13;16(6):231-235. doi: 10.1002/cld.920. eCollection 2020 Dec.
6
Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review.酒精成瘾、肠道微生物群与酒精中毒治疗:综述
Int J Mol Sci. 2020 Sep 3;21(17):6413. doi: 10.3390/ijms21176413.
7
Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases.液体活检在病毒性肝炎、脂肪性肝病和酒精性肝病诊断中的应用。
Int J Mol Sci. 2020 May 25;21(10):3732. doi: 10.3390/ijms21103732.
8
Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease.酒精性肝病中的酒精代谢酶、微粒体乙醇氧化系统、细胞色素P450 2E1、过氧化氢酶和乙醛脱氢酶
Biomedicines. 2020 Mar 4;8(3):50. doi: 10.3390/biomedicines8030050.
9
Association of Bone Metabolism with Fatty Liver Disease in the Elderly in Japan: A Community-based Study.日本老年人骨代谢与脂肪肝疾病的关联:一项基于社区的研究。
Intern Med. 2020 May 15;59(10):1247-1256. doi: 10.2169/internalmedicine.3906-19. Epub 2020 Feb 26.
10
Fatty liver and mortality: a cohort population study in South Italy.脂肪肝与死亡率:意大利南部的队列人群研究。
BMJ Open. 2019 Jun 20;9(6):e027379. doi: 10.1136/bmjopen-2018-027379.
Clin Liver Dis. 2004 Aug;8(3):535-47, viii. doi: 10.1016/j.cld.2004.04.007.
4
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床特征、诊断及自然病史。
Clin Liver Dis. 2004 Aug;8(3):521-33, viii. doi: 10.1016/j.cld.2004.04.004.
5
Epidemiology of nonalcoholic fatty liver.非酒精性脂肪性肝病的流行病学
Clin Liver Dis. 2004 Aug;8(3):501-19, vii. doi: 10.1016/j.cld.2004.04.008.
6
Hepatocellular carcinoma with nonalcoholic steatohepatitis.伴有非酒精性脂肪性肝炎的肝细胞癌
J Gastroenterol. 2004;39(4):391-6. doi: 10.1007/s00535-003-1308-3.
7
Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients.
Dig Dis Sci. 2003 Oct;48(10):1909-13. doi: 10.1023/a:1026152415917.
8
Advances in the understanding and treatment of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的认识与治疗进展
Drugs. 2003;63(22):2379-94. doi: 10.2165/00003495-200363220-00001.
9
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.非酒精性脂肪性肝病的自然史:一项临床组织病理学研究。
Am J Gastroenterol. 2003 Sep;98(9):2042-7. doi: 10.1111/j.1572-0241.2003.07659.x.
10
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.非酒精性脂肪性肝炎肝硬化与丙型肝炎肝硬化的长期预后比较。
Hepatology. 2003 Aug;38(2):420-7. doi: 10.1053/jhep.2003.50320.